← All Aquestive Therapeutics, INC filings

Aquestive Therapeutics, INC Form 4 insider transactions

NASDAQ
AQST
Aquestive Therapeutics, INC
Form 4: Aquestive Therapeutics Executive Peter E. Boyd Reports Stock and Option Awards
Peter E. Boyd, an executive at Aquestive Therapeutics, reported the acquisition of restricted stock and stock options, along with a correction to a previous filing regarding shares beneficially owned.
NASDAQ
AQST
Aquestive Therapeutics, INC
Form 4: Aquestive Therapeutics Executive Stephen Wargacki Reports Changes in Beneficial Ownership
Stephen Wargacki, SVP of Research & Development at Aquestive Therapeutics, reports acquisition and disposal of common stock and derivative securities.